Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joseph K Schachle is Chief Operating Officer at Opus Genetics. OQRO lists 1 transaction filed with the SEC under this name, the latest on Oct 27, 2026, each linked to the official Form 4.
Chief Operating Officer
Disclosures on record
1
Companies involved
1
Oct 23, 2026Sold~$17Kdisclosed Oct 27
DetailsOfficial recordAs of the latest filing on , Joseph K Schachle reported holding 286,673 shares of Opus Genetics (IRD), worth about $1.16M at the last close of $4 (Nov 16, 2026). In the last 12 months, Joseph K Schachle sold $17K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Opus Genetics IRD | 286,673 | 287K direct | $4 | $1.16M | Oct 23, 2026 |
Is this Joseph K Schachle’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Joseph K Schachle bought shares on the open market in 2024, and has not bought since 2024. Sales in 1 of the 3 years since 2024.
Joseph K Schachle reported 1 open-market purchase and 1 sale since 2024; purchases in 2024.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $17K1×1 trade |
| 2024 | $4.1K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 23, 2026, Joseph K Schachle reported holding 286,673 shares of Opus Genetics (IRD). At the last close of $4 on Nov 16, 2026, that is about $1.16M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Joseph K Schachle reported 1 open-market sale worth $17K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Joseph K Schachle bought shares on the open market in 2024, and has not bought since 2024. Sales in 1 of the 3 years since 2024.
In SEC filings since 2024: the latest open-market purchase is from 2024; the latest open-market sale is from 2026.
Opus Genetics (IRD), from 2024 to 2026: 1 purchase and 1 sale.
Joseph K Schachle reported 1 open-market purchase and 1 sale here, 2024 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.